Previous 10 | Next 10 |
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its fourth quarter and fiscal year 2019 financial results after the market close on Monday, February 24, 2020. The Company will host a conference call the following morning, Tuesday, February 2...
Biotech, hands down, wins the race for out-performance in the healthcare sector. Delivering new, valuable medicines has proven to be a winning strategy, even if the growth in their stocks is based on the hope of future drugs. However, this list focuses on the top 10 healthcare stocks in 2019, n...
The U.S. Food and Drug Administration has approved more than 145 new drugs since the start of 2017, and a few more could join their ranks in the remaining days of this year. A quick search of the National Institutes of Health clinical trial database finds that pharmaceutical and biotech companie...
The following slide deck was published by Medpace Holdings, Inc. in conjunction with their 2019 Q3 earnings Read more ...
Image source: The Motley Fool. Medpace Holdings, Inc. (NASDAQ: MEDP) Q3 2019 Earnings Call Oct 29, 2019 , 9:00 a.m. ET Operator Continue reading
Medpace Holdings, Inc. (MEDP) Q3 2019 Results Earnings Conference Call October 29, 2019 9:00 AM ET Company Participants Kevin Brady - Executive Director of Finance August Troendle - President and Chief Executive Officer Jesse Geiger - Chief Financial Officer and Chief Operating O...
Medpace Holdings (NASDAQ: MEDP ) Q3 results : More news on: Medpace Holdings, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, Read more ...
Medpace (NASDAQ: MEDP ): Q3 Non-GAAP EPS of $0.71 in-line; GAAP EPS of $0.63 misses by $0.02 . More news on: Medpace Holdings, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Revenue of $216.2 million in the third quarter of 2019 increased 20.6% from revenue of $179.3 million for the comparable prior-year period, representing a backlog conversion rate of 18.5%. Net new business awards were $285.4 million in the third quarter of 2019, representing an incr...
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its third quarter 2019 financial results after the market close on Monday, October 28, 2019. The Company will host a conference call the following morning, Tuesday, October 29, 2019, at 9:00 a....
News, Short Squeeze, Breakout and More Instantly...
Medpace Holdings Inc. Company Name:
MEDP Stock Symbol:
NASDAQ Market:
Medpace Holdings Inc. Website:
Revenue of $528.1 million in the second quarter of 2024 increased 14.6% from revenue of $460.9 million for the comparable prior-year period, representing a backlog conversion rate of 18.2%. Net new business awards were $551.0 million in the second quarter of 2024, representing a decrease ...
A look at the top 10 most actives in the United States Conduit Pharmaceuticals Inc. (CDT) rose 40.0% to $0.3361 on volume of 63,970,490 shares Yoshitsu Co. Ltd (TKLF) rose 64.0% to $0.5024 on volume of 62,618,792 shares Silo Pharma Inc. (SILO) rose 91.8% to $2.0522 on volume of 59,055,593...
A look at the top 10 most actives in the United States Qualigen Therapeutics Inc. (QLGN) rose 111.4% to $0.4341 on volume of 412,713,755 shares Maxeon Solar Technologies Ltd. (MAXN) fell 1.3% to $0.2375 on volume of 280,800,277 shares NVIDIA Corporation (NVDA) rose 1.4% to $129.24 on volu...